BILHA CANDELARIA: Open Payments
NPI 1609017623 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 33 payments from 10 companies in 2025. Trend: 2023 $853 · 2024 $1,367 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $784 |
| Amgen Inc. | 9 | $182 |
| Lilly USA, LLC | 3 | $59 |
| PFIZER INC. | 2 | $35 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| ABIOMED | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: BREZTRI, FARXIGA, AIRSUPRA, OTEZLA, MOUNJARO, GARDASIL 9, Cologuard Collection Kit, XIFAXAN.
Industry payments across TX — which companies pay providers there.
